Out-licensing

Messenger Biopharma will not develop its own mRNA products.

We are eager to out-license our Aegis biotechnology to pharmaceutical and biotech companies for vaccine and gene therapy products development.

Last news

soiree-laureats

Réseau entreprendre Auvergne celebrates its new Laureates

posted June 20, 2016

“Réseau entreprendre Auvergne celebrates its ...Read More